AI-defined business systems with human accountability.

LibraMedical

A physician safety checklist assistant concept for catching missing monitoring and documentation context before small gaps become preventable misses.

LibraMedical studies how governed intelligence can help clinical teams organize evidence, review checklist context, and keep source-backed questions visible while authority, review, and accountability remain with qualified humans.

Physician-support cockpit

LibraMedical does not decide care. It gives the physician a compact review surface for source-backed checklist prompts, missing-context checks, review state, rationale, and traceable evidence.

Virgil can also answer reference questions from approved source packets, manufacturer labels, and guideline anchors. The answer stays in reference territory: source IDs, known warning or interaction-context categories, and related Checklist cards for physician review.

Current research coverage includes five medication contexts and five Virgil reference reports. Each report is validated against source packets and Checklist rules before it can appear in the physician-support lane.

Thyroid medication and major weight change

Consider whether thyroid replacement monitoring is current after substantial weight change.

Thyroid lab context

Medication-dose review context

Follow-up timing

Symptoms or monitoring notes

Metformin and vitamin B12 context

Consider whether metformin-related vitamin B12 and hematologic monitoring context is current.

B12 monitoring context

Hematologic context

Duration or risk-factor notes

Follow-up documentation

ACEI/ARB kidney and potassium context

Consider whether kidney function and potassium monitoring context is current for a patient taking ACE inhibitor or ARB therapy.

Creatinine or eGFR context

Serum potassium context

Start or dose-change timing

Concurrent medication context

Anticoagulant bleeding and renal context

Review whether anticoagulant monitoring context, renal function context, bleeding-related documentation context, interacting medication context, and follow-up timing are current.

Renal function context

Bleeding-related documentation

Interacting medication context

Follow-up timing

Statin liver and muscle context

Review whether statin adverse-effect documentation context, liver-related context, muscle-symptom context, interacting medication context, and follow-up timing are current.

Liver-related context

Muscle-symptom context

Interacting medication context

Medication list context

Dictated note review

A physician-facing note surface highlights checklist context from example inputs without handling patient records.

Source-backed prompt

Each prompt traces to a source packet, freshness register, and review status.

Virgil reference guide

Virgil can surface manufacturer-label and guideline context for physician review, with source IDs, known context categories, and no action taken.

Physician disposition

The physician can acknowledge, add to a visit checklist, dismiss with rationale, or open source basis.

Virgil reference transcripts

Source-backed reference, not clinical execution

The current reference set includes five Virgil transcripts. Each answer must stay in reference territory: source context, source IDs, related Checklist card, clinician review only, and no silent action.

Physician asks

What source context is available for thyroid replacement monitoring after substantial weight change and GLP-1 context?

Virgil responds

Reference material reports thyroid replacement monitoring context, substantial body-weight-change context, oral medication absorption context, and follow-up documentation context as source-backed review categories.

Source IDsCLIN-ATA-HYPOTHYROID-2014, CLIN-LEVOXYL-LABEL, CLIN-OZEMPIC-LABEL, CLIN-WEGOVY-LABEL

Related Checklist cardLM-CHECK-THYROID-WEIGHT-001

Physician asks

What source context is available for metformin and vitamin B12 monitoring?

Virgil responds

Reference material reports vitamin B12 and hematologic monitoring context as source-backed review categories for metformin therapy.

Source IDsCLIN-METFORMIN-LABEL-2026, CLIN-ADA-STANDARDS-2026

Related Checklist cardLM-CHECK-METFORMIN-B12-001

Physician asks

What source context is available for ACE inhibitor or ARB kidney and potassium review?

Virgil responds

Reference material reports kidney function, serum potassium, therapy-timing, concurrent medication, and follow-up timing context as source-backed review categories.

Source IDsCLIN-KDIGO-CKD-2024, CLIN-LISINOPRIL-LABEL-2026, CLIN-LOSARTAN-LABEL-2025

Related Checklist cardLM-CHECK-ACEI-ARB-KIDNEY-POTASSIUM-001

Physician asks

What manufacturer or guideline context is available for anticoagulant bleeding-related and renal-function review?

Virgil responds

Reference material reports bleeding-related, renal-function, interacting medication, indication, and follow-up timing context as source-backed review categories.

Source IDsCLIN-ELIQUIS-LABEL-2025, CLIN-XARELTO-LABEL-2026, CLIN-ACC-AHA-AF-2023

Related Checklist cardLM-CHECK-ANTICOAG-BLEEDING-RENAL-001

Physician asks

What source context is available for statin liver-related and muscle-symptom review?

Virgil responds

Reference material reports liver-related, muscle-symptom, interacting medication, medication-list, and follow-up timing context as source-backed review categories.

Source IDsCLIN-ATORVASTATIN-LABEL-2026, CLIN-ROSUVASTATIN-LABEL-2026, CLIN-ACC-AHA-CHOLESTEROL-2018

Related Checklist cardLM-CHECK-STATIN-LIVER-MUSCLE-001

Evidence-first build lane

The current lane is built from source packets, validator checks, review queues, claim boundaries, and readiness evidence. A new checklist item must pass review before it can become a rule or cockpit card.

Evidence artifacts

Launch packet

Claims redline guard

Source packet validator

Source review queue

Cockpit interaction harness

Release readiness audit